Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old.
- People who have type 2 diabetes that is considered difficult to control, meaning their HbA1c blood sugar level is between 7.5% and 11.5%, AND they are taking three or more diabetes medications; OR they are taking insulin along with other diabetes medications; OR they are taking two or more diabetes medications AND have one or more diabetes-related complications (such as eye, kidney, nerve, or heart disease linked to diabetes) and/or high blood pressure that requires two or more blood pressure medications.
Who may not be able to join:
- People with Type 1 diabetes, diabetes diagnosed less than one year ago, or other specific types of diabetes.
- People who have used steroid medications (taken by mouth or injection) in the last 3 months — note that inhaled or skin-applied steroids do not count toward this.
- People who are currently pregnant or breastfeeding.
- People with serious problems affecting the heart, liver, kidneys, or other major organs.
- People who have had a serious diabetes emergency, such as diabetic ketoacidosis or a hyperosmolar hyperglycemic episode, within the last 3 months.
- People who have a condition that significantly affects the body's metabolism, such as cancer or an autoimmune disorder.
- People who cannot tolerate adhesive tape on their skin, who have a serious skin condition at the area where a monitoring sensor would be placed, or who have a psychiatric illness or cognitive impairment that could make it difficult to follow study requirements.
- People who have been diagnosed with Cushing's syndrome, or who are currently taking any of the following medications: mifepristone, metyrapone, osilodrostat, ketoconazole, fluconazole, aminoglutethimide, etomidate, octreotide, larazotide, long-acting octreotide, or pasireotide.
- People who drink more alcohol than 14 units per week (for males) or 7 units per week (for females).
- People who have severe sleep apnea that is not currently being treated.
- People who work night shifts, defined as being awake between 11:00 PM and 7:00 AM.
- People with a known allergy or serious reaction to dexamethasone.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-021-64369181
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of Hypercortisolism
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.